United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Purchases New Position in DaVita Inc. (NYSE:DVA)

United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund acquired a new stake in shares of DaVita Inc. (NYSE:DVA) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 3,000 shares of the company’s stock, valued at approximately $449,000.

Other institutional investors have also recently added to or reduced their stakes in the company. SBI Securities Co. Ltd. bought a new position in shares of DaVita during the 4th quarter valued at $41,000. Quarry LP acquired a new stake in shares of DaVita in the third quarter worth about $60,000. Venturi Wealth Management LLC boosted its stake in shares of DaVita by 59.8% during the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock worth $61,000 after acquiring an additional 152 shares in the last quarter. Versant Capital Management Inc increased its holdings in shares of DaVita by 58.7% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $68,000 after acquiring an additional 169 shares during the last quarter. Finally, Blue Trust Inc. increased its holdings in shares of DaVita by 39.7% during the 4th quarter. Blue Trust Inc. now owns 461 shares of the company’s stock valued at $76,000 after acquiring an additional 131 shares during the last quarter. 90.12% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

DVA has been the subject of a number of analyst reports. StockNews.com cut shares of DaVita from a “buy” rating to a “hold” rating in a research note on Friday, March 21st. Cowen reiterated a “hold” rating on shares of DaVita in a research report on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 target price on shares of DaVita in a research report on Friday, February 21st. Finally, Barclays raised their target price on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 18th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $166.33.

DaVita Stock Up 0.3 %

Shares of DVA opened at $151.30 on Thursday. The company has a market capitalization of $12.10 billion, a P/E ratio of 14.09, a PEG ratio of 1.07 and a beta of 0.99. DaVita Inc. has a one year low of $125.64 and a one year high of $179.60. The business’s 50 day simple moving average is $157.96 and its 200-day simple moving average is $157.53. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21.

DaVita (NYSE:DVA) last posted its quarterly earnings data on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, sell-side analysts predict that DaVita Inc. will post 10.76 EPS for the current fiscal year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.